相关实验视频
Updated: Sep 17, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.3K
炎症因素和炎症性肠病之间的因果关系:双向的门德尔随机化研究与元分析相结合
1Anorectal Center, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui Province, China.
Medicine
|June 30, 2025
概括
这项研究使用了门德尔的随机化来研究炎症因素和炎症性肠病 (IBD). 发现C-X-C基因化学物质9 (CXCL9) 导致IBD,特别是性结肠炎 (UC) 的风险增加.
科学领域:
- 遗传学和流行病学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 传统的观察性研究在确定炎症因素与炎症性肠病 (IBD) 之间的因果关系方面存在局限性.
- 研究特定炎症媒介在IBD病变发生过程中的病因作用对于治疗的发展至关重要.
研究的目的:
- 使用孟德尔随机化 (MR) 评估91种炎症因素和IBD之间的因果关系.
- 研究炎症因素与IBD亚型,克罗恩病 (CD) 和性结肠炎 (UC) 的特定因果关系.
- 验证潜在的因果关系,并探索IBD的治疗点.
主要方法:
- 采用两样本的门德尔随机化 (MR) 方法,利用全基因组关联研究 (GWAS) 数据对91种炎症因素和IBD.
- 使用逆变量加权 (IVW),MR-Egger回归和加权中位数估计方法进行因果推断.
- 进行IVW结果的元分析,随后进行多次测试校正和反向因果关系验证.
主要成果:
- 在两个独立的GWAS数据库 (P < .001) 中,C-X-C动机化学素9 (CXCL9) 与IBD风险有显著的积极因果关系.
- 分析证实CXCL9和IBD之间存在强有力的因果关系 (OR = 1.27,P = .001).
- CXCL9与性结肠炎 (UC) 有显著的因果关系 (P = .0004),但与克罗恩病 (CD) 没有. 反向MR分析表明IBD或UC对CXCL9水平没有因果关系.
结论:
- CXCL9在IBD的发展中起着因果作用,特别是增加了UC的风险.
- CXCL9充当疾病进展风险因素,突出其作为UC治疗点的潜力.
- 这些发现强调了MR在识别IBD病原体相关的因果炎症调解者的实用性.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
342
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
342
Inflammatory Bowel Disease II: Crohn's Disease
399
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
399
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Chronic Bowel Disorders: Introduction
542
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
542
Irritable Bowel Syndrome I: Introduction
399
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
399
Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204

